Protagenic Therapeutics, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.1637 USD
−5.53 M USD
0.00 USD
1.84 M
About Protagenic Therapeutics, Inc.
Sector
Industry
Website
Headquarters
New York
Founded
1994
Identifiers
3
ISIN US74365N1110
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Displays a symbol's price movements over previous years to identify recurring trends.